Skip to main content
Kolon TissueGene, Inc. logo

Kolon TissueGene, Inc. — Investor Relations & Filings

Ticker · 950160 ISIN · KR8840120008 LEI · 5493000SYYLC88FUL781 KO Manufacturing
Open in API
Filings indexed 288 across all filing types
Latest filing 2019-07-03 Legal Proceedings Report
Country US United States of America
Listing KO 950160

About Kolon TissueGene, Inc.

https://www.tissuegene.com/

Kolon TissueGene, Inc. is a clinical-stage biopharmaceutical company specializing in the development of advanced cell and gene therapies for orthopedic diseases and degenerative disorders. The company's lead product candidate, TG-C, is a first-in-class, allogeneic cell and gene therapy designed to treat knee osteoarthritis. The therapy aims to reduce pain, improve joint function, and slow the progression of the disease. TG-C is currently in late-stage clinical development, undergoing Phase 3 trials.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항(인보사케이주 품목허가 취소(2019.7.9일자))
Legal Proceedings Report Classification · 95% confidence The document is a regulatory filing from Kolon TissueGene regarding the revocation of the product license for 'Invossa-K' by the Ministry of Food and Drug Safety. It details a significant regulatory action and legal/administrative consequence for the company's product. Since it describes a specific regulatory event and legal outcome rather than a general report or financial update, it falls under the 'Regulatory Filings' category as a fallback for specific corporate announcements of this nature.
2019-07-03 Korean
본점소재지변경
Regulatory Filings Classification · 95% confidence The document is a short, structured announcement regarding a change in the company's registered office address (headquarters location). It does not fit into financial reporting, governance, or shareholder meeting categories. As it is a standard regulatory disclosure regarding corporate administrative changes that does not fall into the other specific categories, it is classified as a general regulatory filing.
2019-06-28 Korean
기타시장안내(실질심사 대상여부 결정을 위한 조사기간 연장 안내)
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice from the Korea Exchange regarding the extension of the investigation period for the eligibility of Kolon TissueGene for continued listing. It does not contain financial statements, proxy materials, or dividend information. As it is a regulatory announcement regarding listing status and investigation timelines, it falls under the general regulatory filing category.
2019-06-19 Korean
소송등의제기ㆍ신청(일정금액이상의청구)
Legal Proceedings Report Classification · 100% confidence The document is a formal regulatory disclosure regarding a lawsuit ('소송등의제기ㆍ신청') filed against Kolon TissueGene. It details the nature of the claim (damages), the amount involved, the court, and the company's planned response. This fits the definition of a Legal Proceedings Report (LTR) as it concerns significant legal matters involving the company.
2019-06-13 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding a change in the company's Chief Executive Officer (CEO). It explicitly lists the 'before' and 'after' representatives, the reason for the change (resignation), and the effective date. This falls directly under the category of board or management changes.
2019-06-05 Korean
기타시장안내(상장적격성 실질심사 대상결정 기한 안내)
Regulatory Filings Classification · 95% confidence The document is a short notice from the stock exchange regarding the timeline for a 'listing eligibility review' (상장적격성 실질심사) for Kolon TissueGene. It is a regulatory announcement concerning trading status and procedural deadlines, which does not fit into specific categories like financial reports or M&A, making it a general regulatory filing.
2019-05-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.